APP and Alzheimer disease: Consistent with the currently widely recognized amyloid cascade hypothesis that puts intracellular degradation of the amyloid precursor protein (APP) into the centre of AD’s pathophysiology [37], impairments of neuropsychological memory subtests were related to lower CSF Aβ1-42 levels.